Zaklady Farmaceutyczne Polpharma
Poland
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (28)
○ MHRA GMP
✓ HC GMP (3)
Quick Facts: Zaklady Farmaceutyczne Polpharma
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Poland
- Website
- https://polpharma.com/
- Modalities
- Small Molecule API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Zaklady Farmaceutyczne Polpharma
Zaklady Farmaceutyczne Polpharma makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://polpharma.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Zaklady Farmaceutyczne Polpharma FDA Inspection History
2025-10
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-10-17 |
Zaklady Farmaceutyczne Polpharma S.A.
Starogard Gdanski
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Nov 01, 2026
Zaklady Farmaceutyczne Polpharma EMA GMP Compliance 28 certificates
2026-07
2026-07
2026-07
2026-03
2026-03
2025-12
2025-10
2025-06
2025-06
2025-05
2025-04
2025-04
2024-11
2024-11
2024-07
2024-01
2023-12
2023-12
2023-10
2023-09
2023-07
2023-07
2023-06
2023-01
2022-08
2022-08
2022-06
2022-06
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| ISF.405.102.2026.IP.1.1 WTC/0105_02_01/209 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2026-07-03 | COMPLIANT |
| ISF.405.102.2026.IP.2 WTC/0105_02_06/210 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2026-07-03 | COMPLIANT |
| ISF.405.102.2026.IP.3.1 WTC/0105_02_01/215 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2026-07-03 | COMPLIANT |
| ISF.405.46.2026.IP.1 WTC/0105_01_01/78 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2026-03-06 | COMPLIANT |
| ISF.405.46.2026.IP.2 WTC/0105_06_01/79 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2026-03-06 | COMPLIANT |
| ISF.405.48.2026.IP.1 WTC/0105_01_01/85 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2025-12-19 | COMPLIANT |
| ISF.405.135.2025.IP.1 WTC/0105_02_01/300 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2025-10-17 | COMPLIANT |
| ISF.405.92.2025.MP.1 WTC/0105_03_01/196 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2025-06-06 | COMPLIANT |
| ISF.405.92.2025.MP.2 WTC/0105_03_01/197 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2025-06-06 | COMPLIANT |
| ISF.405.95.2025.MP.1 WTC/0105_01_03/208 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2025-05-30 | COMPLIANT |
| ISF.405.63.2025.MP.1 WTC/0105_02_02/146 | Zaklady Farmaceutyczne Polpharma S.A. | Poland | 2025-04-11 | COMPLIANT |
| ISF.405.63.2025.MP.2 WTC/0105_02_02/147 | Zaklady Farmaceutyczne Polpharma S.A. | Poland | 2025-04-11 | COMPLIANT |
| ISF.405.12.2025.IP.1 WTC/0105_02_01/23 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2024-11-28 | COMPLIANT |
| ISF.405.12.2025.IP.2 WTC/0105_02_01/24 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2024-11-28 | COMPLIANT |
| ISF.405.98.2024.IP.1 WTC/0105_07_01/173 | Zaklady Farmaceutyczne Polpharma S.A. | Poland | 2024-07-10 | COMPLIANT |
| ISF.405.38.2024.IP.1 WTC/0105_02_04/65 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2024-01-25 | COMPLIANT |
| ISF.405.22.2024.IP.1 WTC/0105_02_06/38 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2023-12-15 | COMPLIANT |
| ISF.405.22.2024.IP.2 WTC/0105_02_01/39 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2023-12-15 | COMPLIANT |
| ISF.405.55.2023.IP.1 WTC/0105_02_04/256 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2023-10-06 | COMPLIANT |
| ISF.405.50.2023.IP.1 WTC/0105_01_03/241 | Zaklady Farmaceutyczne Polpharma S.A. | Poland | 2023-09-21 | COMPLIANT |
| ISF.405.19.2023.IP.1 WTC/105_01_01/188 | Zaklady Farmaceutyczne Polpharma S.A. | Poland | 2023-07-06 | COMPLIANT |
| ISF.405.19.2023.IP.2 WTC/0105_06_01/189 | Zaklady Farmaceutyczne Polpharma S.A. | Poland | 2023-07-06 | COMPLIANT |
| IWSF.405.79.2023.IP.1 WTC/0105_02_01/147 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2023-06-16 | COMPLIANT |
| IWSF.405.24.2023.IP.1 WTC/0105_02_01/57 | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. | Poland | 2023-01-13 | COMPLIANT |
| IWSF.405.125.2022.IP.1 WTC/0105_03_01/276 | Zaklady Farmaceutyczne Polpharma S.A. | Poland | 2022-08-26 | COMPLIANT |
| IWSF.405.125.2022.IP.2 WTC/0105_03_01/277 | Zaklady Farmaceutyczne Polpharma S.A. | Poland | 2022-08-26 | COMPLIANT |
| IWSF.405.103.2022.IP.1 WTC/0105_02_03/239 | Zaklady Farmaceutyczne Polpharma S.A. | Poland | 2022-06-10 | COMPLIANT |
| IWSF.405.103.2022.IP.2 WTC/0105_02_02/240 | Zaklady Farmaceutyczne Polpharma S.A. | Poland | 2022-06-10 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 01, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 31, 2026
Frequently Asked Questions About Zaklady Farmaceutyczne Polpharma
How many FDA inspections does Zaklady Farmaceutyczne Polpharma have on record?
CDMO Signal tracks 1 FDA inspection for Zaklady Farmaceutyczne Polpharma, sourced from the FDA inspection database. See the full inspection history above.
Has Zaklady Farmaceutyczne Polpharma received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Zaklady Farmaceutyczne Polpharma.
Does Zaklady Farmaceutyczne Polpharma hold EMA or MHRA GMP certificates?
CDMO Signal tracks 28 EMA GMP certificates for Zaklady Farmaceutyczne Polpharma.
Does Zaklady Farmaceutyczne Polpharma have a CDMO Signal Score?
Not yet. Zaklady Farmaceutyczne Polpharma is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Zaklady Farmaceutyczne Polpharma for a manufacturing program?
Use the free AI matchmaker to compare Zaklady Farmaceutyczne Polpharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Olon
Rodano (Milano), Italy
Small Molecule API, Biologics, ADC / Bioconjugation
Sterling Pharma Solutions
Cramlington, United Kingdom
Small Molecule API, High-Potency APIs, Peptides, ADC / Bioconjugation, Controlled Substances, Clinical Trial Manufacturing
Veranova
United States
Small Molecule API, ADC / Bioconjugation
Sai Life Sciences
India
Small Molecule API
EUROAPI
France
Small Molecule API, Oligonucleotide, Peptides, Lipids, Microbial Fermentation, Particle Engineering
Compare Zaklady Farmaceutyczne Polpharma with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.